Norwegian biotech group Hofseth BioCare inks 'tremendous' distribution deal in pan-Asian launch

This distribution agreement with Swiss group DKSH now provides Hofseth with global access for the delivery of its nutritional and nutraceutical grade products.

Roger Hofseth, CEO of Norwegian biotechnology company Hofseth BioCare.
Roger Hofseth, CEO of Norwegian biotechnology company Hofseth BioCare.Foto: Pressefoto
Published 8 December 2020, 13:31Updated 8 December 2020, 13:31